# Delgocitinib ointment, a topical Janus kinase inhibitor, in adult patients with moderate to severe atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/delgocitinib-ointment-a-topical-janus-kinase-inhibitor-in-adult-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hidemi Nakagawa,Osamu Nemoto,Atsuyuki Igarashi,Hidehisa Saeki,Hironobu Kaino,Takeshi Nagata |
| Citations | 238 |
| DOI | 10.1016/j.jaad.2019.12.015 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://doi.org/10.1016/j.jaad.2019.12.015 |
| OpenAlex ID | https://openalex.org/W3004398344 |
| PMID | 32029304 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Hidehisa Saeki](https://scholariq.org/researchers/hidehisa-saeki/)

## Paper primary topic

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)

## Paper topics

- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Allergic Rhinitis and Sensitization](https://scholariq.org/topics/allergic-rhinitis-and-sensitization/)
- [Psoriasis: Treatment and Pathogenesis](https://scholariq.org/topics/psoriasis-treatment-and-pathogenesis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.